Jacobs Levy Equity Management’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
GKFF
Jacobs Levy Equity Management's ASPN Position: Q2 2026 in Review
Jacobs Levy Equity Management increased its Aspen Aerogels (ASPN) stake by 69% in Q2 2026, buying an estimated $4.12M and bringing the position to 2,058,083 shares worth $13M. The position accounts for 0.05% of the portfolio, ranked #280.
Jacobs Levy Equity Management first reported a position in ASPN in Q2 2015 and has held it in 19 quarters since. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.
- Jacobs Levy Equity Management held 2,058,083 shares of Aspen Aerogels worth $13M as of Q2 2026.
- Jacobs Levy Equity Management bought 839,304 Aspen Aerogels shares in Q2 2026, an estimated $4.12M.
- Aspen Aerogels made up 0.05% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #280 holding.
- Jacobs Levy Equity Management first reported a position in Aspen Aerogels in Q2 2015 and has held it in 19 quarters since.
- 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.